J&J seeks permission for phase-3 trial of its single-shot COVID vaccine in India, import licence - The Economic Times
Johnson & Johnson Begins Two-Dose Phase 3 Trial Of COVID-19 Vaccine
J&J trims the size of its phase 3 COVID-19 vaccine trial - PMLiVE
Johnson & Johnson pulls Africa HIV vaccine trial; but pledges to continue with Phase 3 Mosaico study
Coronavirus: Johnson & Johnson beginnt Phase-3-Studie für Impfstoff gegen Sars-CoV-2 - manager magazin
Johnson & Johnson Sends Booster Vaccine Data to FDA. What Comes Next. | Barron's
Johnson & Johnson Single-Shot COVID-19 Vaccine Meets Primary Endpoints in Interim Analysis of Phase 3 Trial | Technology Networks
Johnson & Johnson is 'comfortable' meeting coronavirus vaccine delivery promises, CFO says | Fierce Pharma
Coronavirus vaccine: Johnson & Johnson begins late-stage Covid trial
J&J says vaccine effective against Covid, though weaker against South Africa variant
Johnson & Johnson's COVID-19 Vaccine Candidate Enters Phase 3 Trial
New Phase 3 Trial Data Suggest Johnson & Johnson's COVID-19 Vaccine Could Be Efficacious Against Newly Emerging Variants | The New York Academy of Sciences
5 Facts About Johnson & Johnson's Investigational Janssen COVID-19 Vaccine Candidate
Johnson & Johnson Covid-19 vaccine study paused due to illness
J&J starts COVID-19 vaccine phase 3, eyes early 2021 approval | Fierce Biotech
EU sichert potenzielle Corona-Impfstoffe bei Johnson & Johnson
The 5 Stages of COVID-19 Vaccine Development: What You Need to Know About How a Clinical Trial Works | Johnson & Johnson
J&J Seeks Permission For Phase-3 Trial of Its COVID Vaccine in India
Nicorette Pflaster mit 25 mg Nikotin 14 stk
Temple University Hospital Begins Recruiting Participants for Phase 3 COVID-19 Vaccine Clinical Trial | Lewis Katz School of Medicine at Temple University
Aktuell | ERGOMED Landau
Johnson & Johnson pauses COVID-19 vaccine trial due to an unexplained illness
